Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Soluble yeast beta-1,3/1,6-glucan

EU orphan designation number: EU/3/05/294   
Active ingredient: Soluble yeast beta-1,3/1,6-glucan
Indication: Prevention of oral mucositis in head and neck cancer patients undergoing radiation therapy
Sponsor: Biotec Pharmacon ASA
Strandgata 3, N-9008 Tromso, Norge

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/06/2005 Orphan designation EMEA/OD/005/05 (2005)1882 of 16/06/2005